Used in bone metabolism research to measure bone resorption levels by detecting NTX fragments in urine or serum. Commonly applied in osteoporosis studies, monitoring response to anti-resorptive therapies, and assessing bone turnover in clinical and preclinical settings. Provides a sensitive and specific quantitative result, enabling researchers to evaluate skeletal health and disease progression. Widely used in pharmaceutical development and metabolic bone disease research.